298 related articles for article (PubMed ID: 23243309)
21. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
Tworkoski K; Raab-Traub N
J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
[TBL] [Abstract][Full Text] [Related]
22. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
23. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
Hermanto U; Zong CS; Li W; Wang LH
Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
[TBL] [Abstract][Full Text] [Related]
24. Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.
Liang R; Khanna A; Muthusamy S; Li N; Sarojini H; Kopchick JJ; Masternak MM; Bartke A; Wang E
Aging Cell; 2011 Dec; 10(6):1080-8. PubMed ID: 21967153
[TBL] [Abstract][Full Text] [Related]
25. IGF1 induces up-regulation of steroidogenic and apoptotic regulatory genes via activation of phosphatidylinositol-dependent kinase/AKT in bovine granulosa cells.
Mani AM; Fenwick MA; Cheng Z; Sharma MK; Singh D; Wathes DC
Reproduction; 2010 Jan; 139(1):139-51. PubMed ID: 19819918
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
Tian D; Kreeger PK
BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3.
Maile LA; Busby WH; Sitko K; Capps BE; Sergent T; Badley-Clarke J; Clemmons DR
Mol Endocrinol; 2006 Feb; 20(2):405-13. PubMed ID: 16195248
[TBL] [Abstract][Full Text] [Related]
28. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells.
Rucci N; DiGiacinto C; Orrù L; Millimaggi D; Baron R; Teti A
J Cell Sci; 2005 Aug; 118(Pt 15):3263-75. PubMed ID: 16014375
[TBL] [Abstract][Full Text] [Related]
29. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
30. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
[TBL] [Abstract][Full Text] [Related]
31. Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB.
Courter DL; Lomas L; Scatena M; Giachelli CM
J Biol Chem; 2005 Apr; 280(13):12145-51. PubMed ID: 15695822
[TBL] [Abstract][Full Text] [Related]
32. The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.
Bareja A; Hodgkinson CP; Soderblom E; Waitt G; Dzau VJ
J Biol Chem; 2018 Apr; 293(17):6449-6459. PubMed ID: 29530981
[TBL] [Abstract][Full Text] [Related]
33. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
34. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
Maile LA; Clemmons DR
Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
Maile LA; Capps BE; Ling Y; Xi G; Clemmons DR
Endocrinology; 2007 May; 148(5):2435-43. PubMed ID: 17255202
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.
Incerpi S; Hsieh MT; Lin HY; Cheng GY; De Vito P; Fiore AM; Ahmed RG; Salvia R; Candelotti E; Leone S; Luly P; Pedersen JZ; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2014 Jul; 307(2):C150-61. PubMed ID: 24808494
[TBL] [Abstract][Full Text] [Related]
37. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
38. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth.
Disser NP; Sugg KB; Talarek JR; Sarver DC; Rourke BJ; Mendias CL
FASEB J; 2019 Nov; 33(11):12680-12695. PubMed ID: 31536390
[TBL] [Abstract][Full Text] [Related]
40. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
